XTalks

JANUARY 3, 2025

For the first time in the US, adults living with familial chylomicronemia syndrome (FCS) have an FDA-approved treatment option. The approval of Tryngolza was based on positive results from the Phase III Balance trial, which showed reductions in triglyceride levels and acute pancreatitis events.

FDA Approval 59

FDA Approval Drugs Clinical Trials Clinical Trials 59

Pharma Marketing Network

FEBRUARY 19, 2025

Why Pharma Needs Email Marketing Direct Access to HCPs : Doctors, pharmacists, and researchers check their emails frequently for industry updates and medical advancements. Patient Education & Support : Email allows pharma companies to provide disease awareness, medication adherence tips, and product updates.

Compliance 72

Compliance Marketing Branding Regulation 72

XTalks

JANUARY 22, 2025

The heart and vascular medication market continues to be a critical focus area for pharma companies, with billions of dollars in sales generated annually. Their widespread adoption is driven by strong clinical evidence, broad FDA-approved indications and continued advancements in treatment protocols.

Sales 104

Sales FDA Approval Drugs Marketing 104